Artículo de revista
Emerging Noninvasive Biomarkers for Early Detection of Alzheimer's Disease
Fecha
2012Registro en:
Archives of Medical Research, Volumen 43, Issue 8, 2018, Pages 663-666
01884409
18735487
10.1016/j.arcmed.2012.10.013
Autor
Guzmán Martínez, Leonardo
Farías, Gonzalo A.
Maccioni Baraona, Ricardo
Institución
Resumen
Alzheimer's disease (AD) diagnosis still depends on the triad of clinical, imaging and neuropsychological testing. The development of accurate, easy to use and inexpensive biological markers for AD is a long-standing aspiration for researchers and the medical community. Here we describe some of the recent advances in the field of biomarkers, both in cerebrospinal fluid (CSF) and in peripheral blood. © 2012 IMSS.